{"acute graft versus host disease": 53.3, "acute kidney injury": 3.7, "acute myeloid leukaemia": 9.16, "adenovirus infection": 51.24, "anaemia": 2.02, "cytomegalovirus infection": 10.87, "cytomegalovirus infection reactivation": 24.61, "febrile neutropenia": 22.8, "haemophagocytic lymphohistiocytosis": 17.23, "incorrect route of product administration": 7.05, "mucosal inflammation": 34.24, "multiple organ dysfunction syndrome": 7.98, "myelodysplastic syndrome": 16.2, "neuropathy peripheral": 5.01, "neutropenia": 5.41, "off label use": 5.75, "pancytopenia": 9.85, "plasma cell myeloma": 29.39, "pleural effusion": 3.06, "product use in unapproved indication": 4.51, "respiratory failure": 4.43, "retinal degeneration": 91.77, "sepsis": 3.13, "septic shock": 6.78, "stomatitis": 5.25, "thrombocytopenia": 4.23, "thrombotic microangiopathy": 33.87, "toxicity to various agents": 3.19, "venoocclusive liver disease": 76.77}